产品名称
胆甾烯醇, Avanti Research™ - A Croda Brand
InChI
1S/C27H48O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h18-25,28H,6-17H2,1-5H3
InChI key
QYIXCDOBOSTCEI-UHFFFAOYSA-N
SMILES string
[H][C@@]12[C@]([C@](CC[C@H](O)C3)(C)C3CC2)([H])CC[C@@]4(C)[C@@]1([H])CC[C@]4([H])[C@]([H])(C)CCCC(C)C
description
5α-cholestan-3β-ol
assay
>99% (TLC)
form
powder
packaging
pkg of 1 × 5 mg (700064P-5mg)
manufacturer/tradename
Avanti Research™ - A Croda Brand
shipped in
dry ice
storage temp.
−20°C
General description
胆甾醇是一种 5α--胆固醇的二氢衍生物。它作为胆固醇吸收的标志物。胆甾醇是一种含有 27 个碳原子的类固醇。
Packaging
5 mL 棕色玻璃螺旋盖小瓶（700064P-5 mg）
Legal Information
Avanti Research is a trademark of Avanti Polar Lipids, LLC
存储类别
11 - Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Addictive Substances and Neurological Disease: Alcohol, Tobacco, Caffeine, and Drugs of Abuse in Everyday Lifestyles, 184(2), 247-254 (2017)
Cholestanol metabolism in patients with cerebrotendinous xanthomatosis: absorption, turnover, and tissue deposition
Bhattacharyya AK, et al.
Journal of Lipid Research, 48(1), 185-192 (2007)
Michel R Hoenig et al.
Atherosclerosis, 184(2), 247-254 (2005-10-12)
Statins have been the mainstay of lipid-lowering therapy since their introduction. However, as lower LDL cholesterol targets are sought, adjunct therapies are becoming increasingly important. Few patients reach new targets with statin monotherapy. We propose that the cholestanol:cholesterol ratio can
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持